imlifidase
Showing 1 - 8 of 8
Kidney Transplantation in Highly Sensitized Patients Trial (Imlifidase)
Not yet recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- (no location specified)
Mar 2, 2023
Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome Trial in
Recruiting
- Anti-Glomerular Basement Membrane Disease
- +3 more
- Imlifidase
- +3 more
-
Chapel Hill, North CarolinaUNC Kidney Center/Division of Nephrology & Hypertension
Dec 23, 2022
Kidney Transplantation in Highly Sensitized Patients Trial in Prague, Barcelona, Madrid (Imlifidase, Normal Transplantation
Recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- Normal Transplantation Routine
-
Vienna, Austria
- +9 more
Jan 24, 2023
Trial of Kidney Tx Patients Treated With Imlifidase or PE
Recruiting
- Kidney Transplant Rejection
- Imlifidase
-
Vienna, Austria
- +4 more
Apr 7, 2022
Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)
Recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- +5 more
-
Birmingham, Alabama
- +12 more
Jan 12, 2023
Guillain-Barré Syndrome (GBS) Trial in France, Netherlands, United Kingdom (Imlifidase)
Recruiting
- Guillain-Barré Syndrome (GBS)
- Imlifidase
-
Le Kremlin-Bicêtre, Paris, France
- +9 more
Mar 31, 2022
Kidney Transplantation in Highly Sensitized Patients Trial in New York (Imlifidase)
Not yet recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
-
New York, New YorkNYU Langone Health Transplant Institute
Sep 9, 2021
Patients Treated With Imlifidase Prior to Kidney Transplantation
Active, not recruiting
- Kidney Transplant Failure and Rejection
- Imlifidase
-
Los Angeles, California
- +5 more
Sep 9, 2021